A new actinomycete strain was isolated from Western part of Bangladesh and identified as a new Streptomyces species on the basis of its morphological, biochemical, cultural characteristics and 16S rRNA data. The present paper describes the isolation and characterization of compound 1 from this new Streptomyces species with the help of various chemical and spectroscopic methods. Antimicrobial activity of compound 1 was tested by disc diffusion assay method and compared with that of standard antibiotics (Kanamycin for antibacterial activity and Nystatin for antifungal activity). The compound has been found to exhibit moderate to strong antimicrobial activity against the test organisms. Cytotoxicity of the compound 1 and the pet. ether extract of Czapek Dox (alkaline) broth of Streptomyces species was evaluated in brine shrimp bioassay with LC 50 values of 23.85 µg/ml (ppm) and 19.95 µg/ml (ppm), respectively.
Introduction
Antibiotic resistant pathogens have been widely and continuously reported. In consequence, novel antibiotics have been isolated from various microorganisms and search for new antibiotics against pathogenic bacteria and fungi are still continued. Soil bacteria and fungi have played a significant role in antibiotic discovery. Streptomyces species have been always a source of thousands of bioactive compounds and screening programs have shown that secondary metabolites can be isolated which bind to active sites of enzyme organelles and receptors [1, 2] . Streptomycetes are rich source of bioactive compounds, notably antibiotics, enzyme inhibitors and pharmacologically active agents [3] . As a result, secondary metabolites produced by Streptomyces have been the primary source of antibiotics and more recently, are used as herbicides, anticancer drugs, immunoregulators and antiparasitic compounds [4] . Recently, research provides a basis for the development of new approaches to combat human diseases [5] . Infectious diseases are leading health problems with high morbidity and mortality in the developing countries [6, 7] . The first systemic search for antibiotics, made by Gratia and Dath around 1924 [8] , resulted in the discovery of actinomycetin from a strain of Actinomycetes. At present, 4,000 antibiotic substances obtained from bacteria and fungi have been applied in medicine, out of which about 75% are produced from Gram-positive actinomycetes bacteria such as Streptomyces sp. [9, 10] . Most of the antibiotics are extracellularsecondary metabolites which are normally secreted in culture media and serve as intermediates from primary metabolisms as precursors for their biosynthetic process [10] . As part of our ongoing research of microbial metabolites [11, 12] , we isolated a new strain of Streptomyces species [13] from a soil sample collected in the region of Kushtia. We, herein, report the isolation of compound 1 from this new species as well as the antimicrobial and cytotoxic activities of this compound and crude pet ether extract of Czapek Dox (alkaline) broth of this new species.
Materials and methods

Collection and identification of organism
The organism was isolated from a soil sample collected from Kushtia, Bangladesh at the depth of 0.75m during the month of september 2003, using crowded plate technique [14] . The 16S rDNA sequence generated in this work was compared with the 16S rDNA sequences of other organisms retrieved from the EMBL/GenBank database. The nearest is being Streptomyces parpurascens, with 99.3% nucleotide similarity. In addition, the morphological, physiological and biochemical properties of the present isolate was also different from Streptomyces parpurascens [13] . On the basis of morphological, physiological, biochemical and sequencing of 16S rDNA studies, the organism was identified as a novel Streptomyces species and named as Streptomyces lalonnensis [13] .
Fermentation
The strain was grown on modified Czapek Dox (alkaline) agar slant at 37.5 o C for 10 days. Spores were collected from a slant culture with 10 ml of the same medium (broth). Cultivation of the strain was made by transferring 1ml (ca. 10 8 cells/ml) of the spore suspension and was incubated at 37.5 o C (at 250 rpm) for ten days in 500 ml Erlenmeyer flasks each containing 100 ml of antibiotic medium consisted of 2 % sucrose, 0.25 % yeast extract, 0.1 % K 2 HPO 4 , 0.05 % MgSO 4 .7H 2 O, 0.001 % FeSO 4 7H 2 O and 0.002% NaCl.
Extraction and isolation
The culture broth (50 × 200 ml) of S. lalonnensis was partitioned with pet ether and ethyl acetate (50 × 60 ml) respectively and concentrated to dryness by using a rotary evaporator under vacuum at 40°C. We could not purify the ethyl acetate extract due to limited facilities and scarcity of time. Preparative TLC of the pet ether soluble part (1.25 gm) over Si gel 60 PF 254 gel using mobile phase, pet. ether:chloroform (10:1) yielded compound 1 (12 mg purple color powder, mp. 110-120 o C).
Antibacterial and antifungal screening
Both antibacterial and antifungal activities of compound 1 and pet ether extract were observed by disc diffusion assay [15, 16] . A total of five Gram positive and nine Gram negative bacteria were used in this antimicrobial screening. Compound 1 and pet. ether extract (100μg/disc and 30μg/disc) were prepared by dissolving with pet. ether. To compare the antibacterial activity, kanamycin (30μg/disc) was used as standard antibiotic. As a negative control, a blank disc impregnated with solvent followed by drying off was used. The antifungal activity of the compound 1 and pet ether were tested against eight pathogenic fungi at a concentration of 200 µg/disc. Potato dextrose agar (PDA) media was used for this purpose. The activity was determined after 72 hours of incubation at room temperature (37 ºC). Nystatin was used as standard at a concentration of 20 µg/disc.
Minimum inhibitory concentration (MIC) assay
The minimum inhibitory concentrations (MIC) were determined by serial dilution technique [17] in the presence of standard Kanamycin (for bacteria) and Nystatin (for fungi). Bacterial and fungal inocula were prepared at 5 × 10 6 -5 × 10 7 cfu/ml. Final adjustment were made using optical density measurement for bacteria (absorbance 0.05 at a wavelength of 660 nm).
Cytotoxicity screening
The eggs of the brine shrimp, Artemia salina, were collected from an aquarium shop (Dhaka, Bangladesh) and hatched for 48 hr to mature shrimp called nauplii. [18, 19] The test samples (extracts and compound) were prepared by dissolving them in DMSO (not more than 50 ml in 5 ml solution) plus sea water (3.8% NaCl in water) to attain concentrations-2.5 mg/ml, 5 mg/ml, 10 mg/ml, 20 mg/ml, 40 mg/ml and 80 mg/ml. A vial containing 50 ml DMSO diluted to 5 ml was used as a control. Then 20 matured shrimps were applied to each of all experimental vials and control vial. The number of the nauplii that died after 24 hr was counted. The findings were presented graphically by plotting log of concentration versus percentage of mortality of nauplii from which LC 50 was determined by extrapolation. The assay was performed in duplicate and the result was calculated as an average of two determinations. The cytotoxicity of the compound 1 was compared with the standard gallic acid and also with the anticancer agent bleomycin.
Results and discussion
Characterization of the compound 1
The compound 1 with R f value 0.92 (Si gel GF 254 , solvent system, pet. ether: chloroform= 10:1) was isolated from pet. ether extract of the metabolites of a new Streptomyces species and was obtained as purple powders with mp. 110-120°C. The compound was found to be odorless and it appeared as a yellowish spot on TLC plate when viewed under UV light (254 nm).
The compound 1 was assigned on the basis of a series of 1D and 2D NMR data (Table  1 ) and mass spectra. The molecular formula of compound 1 was established as C 14 H 23 NO 3 from a molecular ion peak at 253 in the mass spectra. So combination of these two partial structures gives the complete structure of 1. Thus compound 1 is identified as (E)-1-(3-hydroxyazetidin-1-yl) undec-7-ene-1,5-dione ( Figure  1 ). To our best knowledge this is a new compound. 
Antibacterial activity
Both the compound 1 and pet. ether extract showed remarkable biocidal activity (100 µg/disc) against the tested Gram positive and Gram negative bacteria (Table 2 ). In case of some pathogenic bacteria, pet. ether extract was more active than compound 1 which indicated the presence of more bioactive compounds in the extract. When the concentration was 30 µg/disc, none of the test materials showed a remarkable antibacterial activity against the tested bacteria in comparison with the standard kanamycin. In the present investigation we found that, both the compound and extract showed comparatively better antibacterial activity against the Gram positive bacteria than the Gram negative bacteria. 
Antifungal activity
The antifungal activities of the compound 1 and pet ether extract were determined at the concentration of 200 μg/disc against pathogenic fungi. It was found that the pet ether extract had greater activity than the compound 1 against all of the pathogenic fungi (Table  3 ) which may be due to the presence of more bioactive compounds in the crude extract. 
Minimum inhibitory concentration (MIC)
The 
Cytotoxicity assay
The mortality rate of brine shrimp nauplii was found to increase with increasing the concentration of complexes. Table 5 summarizes the LC 50 values of the pet ether extract (2) and the compound 1. The values were found at 19.95 µg/ml (ppm) and 23.85 µg/ml (ppm), respectively. The standard anticancer drug bleomycin and gallic acid gave LC 50 value at 0.41 µg/ml (ppm) and 4.53 µg/ml (ppm), respectively.
